IntroductionUrinary incontinence (UI) has been associated with negative effects on women's sexuality. Women's sexuality and sexual function are a complex issue, and the role of UI is not completely clear.AimTo assess the impact of UI on female sexual function by comparing this population with a control group of continent women.MethodsWe performed a case-control study from August 2012 to September 2013. We evaluated continent and incontinent women (age range = 30–70 years) for their sexuality.Main Outcome MeasuresAll patients were evaluated by anamnesis, physical examination, and self-report quality-of-life questionnaires. In addition, incontinent women underwent a 1-hour pad test. Patients without sexual activity were evaluated for the role of UI in their sexual abstinence. Sexual abstinence was defined as the absence of sexual activity for more than 6 months. All sexually active women completed the self-report Sexuality Quotient–Female Version (SQ-F) questionnaire.ResultsA total of 356 women were included in the study (incontinent, n = 243; continent, n = 113). Sexual abstinence was found in 162 women (45%). Incontinent women presented a higher prevalence (P < .001) of sexual abstinence than their counterparts (129 [53%] and 33 [29.2%], respectively). Age, marital status, and UI were found to be isolated predictive factors for more sexual abstinence in incontinent women. Sexually active women (incontinent, n = 114; continent, n = 80) presented similar demographic data. Despite a similar frequency of sexual activity, incontinent women had less sexual desire, foreplay, harmony with a partner, sexual comfort, and sexual satisfaction than their counterparts. Women with greater urinary leakage during the 1-hour pad test (weight > 11 g) had the worst sexual function (SQ-F) score.ConclusionWomen with UI were more likely to be sexual abstinent than continent women. Furthermore, women with UI showed less sexual desire, sexual comfort, and sexual satisfaction than their counterparts despite having a similar frequency of sexual activity.
INTRODUCTION AND OBJECTIVES: Multiple surgical procedures have been introduced for the treatment of (SUI) with variable morbidities. In this study, the results and long term follow up of fascial modified pubovaginal sling (MPVS) were evaluated.METHODS: from March 1995 to January 2016, 220 female patients complaining of SUI underwent MPVS. Preoperative evaluation included history, physical examination, and uroflow. Full urodynamics were performed in cases of mixed incontinence or recurrent cases. The patients had an average age of 45.7 years and parity 4. The presentations were pure SUI in 84 (38.2%) and mixed incontinence in 136 cases (61.8 %). MPVS (Ghoniem's modification) was performed using a 7 x 2.5 cm patch harvested from the rectus sheath with polypropylene sutures on both sides. With Stamy's needle, the sutures of the patch were guided up to the suprapubic region, and then cystoscopy was performed. The patients were followed up 3, 6, and 12 months, then annually every year up to 20 years in old cases. The patients were subdivided, according to duration of follow up, into 4 groups (I-IV) from 15-20, 10-14, 5-9 and < 5 years respectively.RESULTS: MPVS was performed alone in 157 (71.4%) and accompanied with cystocele and / rectocele repair in 63 cases (28.6 %). Intraoperative and postoperative complications were managed properly. After one year, 205 patients (93.2 %) cured, while 15 patients (6.8 %) failed. Follow up was lost in 20 patients for different causes. For 57 patients in group I, the success rate was reported in 53 (92.9%), 52 (91.2 %), 49 (86%) and 49 cases (86 %) after 5, 10, 15 and 20 years follow up respectively. CONCLUSIONS: MPVS is very simple procedure without major complications. It has a satisfactory long term results and stable with time up to 20 years.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.